University of Louisville Clinical Trials
Sponsors / University of Louisville
University of Louisville appears as lead sponsor on 125 trial records in ClinicalTrials.gov. The portfolio currently includes 18 recruiting studies, 3 active non-recruiting studies, and 79 completed studies. 15 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Cumulative planned enrollment across all listed trials is 28,340 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
125
Total Trials
18
Recruiting
3
Other Active
79
Completed
15
Terminated / Withdrawn
28,340
Total Enrollment
Termination reasons: Other40% · Recruitment40% · Funding13% · PI/or_Site7%
Recent Terminations
- NCT04088435 Stopped Jun 2022Breast Cancer"Low accrual"
- Brain Metastases"per DMSC request"
- Heterotopic Ossification"Difficulty getting radiation therapy for patients and Low enrollment number"
- NCT04121325 Stopped Mar 2020Abdominal Pain"pandemic"
- Atelectasis"slow enrollment, outdated material"
- Tooth Loss"Not enough patients available"
- Depressive Symptoms"COVID epidemic \& measures to control it"
- Sedation"Unable to recruit the adequate number of subjects"
- Distal Radius Fracture"Unable to find sufficient drug naive patients"
- Gliomas"Transition to a different immunotherapy strategy in the future at our institution"
Active Trials (3 total)
- NCT03998527
- NCT03876288
- NCT06804642
- NCT07044557
- Pancreatic Adenocarcinoma PHASE2NCT03080974
- Pancreas Cancer PHASE1NCT03484299
- NCT04208828
- NCT07016945
- NCT06511804
- NCT06883513
- NCT06617338
- NCT04866472
- Endometriosis PHASE4NCT04554693
- NCT04013282
- Chronic Pelvic Pain Syndrome PHASE4NCT06644261
- Appendicitis NANCT05838248
- Bronchiolitis, Viral PHASE2/PHASE3NCT04740294
- NCT03891888
- Cutaneous Melanoma PHASE2NCT03842943
- NCT06353399